The pharmaceutical industry is witnessing a significant shift in the respiratory care segment, driven by changing environmental conditions, a growing geriatric population, and an increase in respiratory ailments. Central to this evolution is the cough syrup sector, which remains a primary frontline treatment for seasonal ailments and chronic conditions alike. The Global Trajectory:...